Start Date
June 30, 2016
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
"Secukinumab Cosentyx TM"
"Secukinumab Cosentyx TM 150 mg PFS (pre-filled syringe) containing for solution for s.c. injection will be applied as 2 units (300 mg dosage) per patient at each visit.~First month: 300 mg injections/week, 4 weeks Starting from 4th week until Week 16, one injection/month"
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY